CDC Expands Recommendations for COVID-19 Booster
November 30, 2021
Written Dr. Rochelle Walensky
U.S. Center for Disease Control and Prevention Director
Atlanta, GA – Monday, November 29th, 2021, the U.S. Center for Disease Control and Prevention (CDC) strengthened its recommendation on booster doses for individuals who are 18 years and older.
Everyone ages 18 and older should get a booster shot either when they are 6 months after their initial Pfizer or Moderna series or 2 months after their initial J&J vaccine.
Tennessee Department of Health offers Third Dose of mRNA Vaccine
August 16, 2021
Nashville, TN – The Tennessee Department of Health (TDH) is acting upon recent guidance from the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) regarding an additional dose of the COVID-19 mRNA vaccine for moderately and severely immunocompromised individuals.
Tennessee Department of Health to begin administering Pfizer COVID-19 Vaccine to Children Ages 12 and Up
May 12, 2021
Nashville, TN – The Tennessee Department of Health has announced it will begin administering the Pfizer COVID-19 vaccine to children ages 12-15 years. This is following the decision by the Advisory Committee on Immunization Practices (ACIP) to recommend to the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) that the Pfizer vaccine be made available to administer to children ages 12-15 years.
Tennessee Department of Health announces Moderna COVID-19 Vaccine to arrive next Week
December 18, 2020
Nashville, TN – The Tennessee Department of Health today announced the state expects to receive its first shipment of the Moderna COVID-19 vaccine on or around December 21st, 2020.
Tennessee expects to receive an initial allocation of a total of 115,000 doses of the Moderna COVID-19 vaccine over the next two weeks, following Emergency Use Authorization issued by the U.S. Food and Drug Administration (FDA) and recommendations released by the Advisory Committee on Immunization Practices.
Moderna, Pfizer COVID-19 Vaccines Begin Final-Stage Testing
July 28, 2020
Washington, D.C. – “Two of the most advanced experimental coronavirus vaccines entered the pivotal phase of their studies on Monday,” Peter Loftus and Jared S. Hopkins report for The Wall Street Journal.
“The start of the pivotal Moderna vaccine trial is the latest sign that the most advanced coronavirus vaccine candidates are moving into the final stages of testing, and could be ready for wider use before year’s end if results are positive.”










